Clinical Trials Logo

Bone Metastases clinical trials

View clinical trials related to Bone Metastases.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06376682 Not yet recruiting - Bone Metastases Clinical Trials

EPIBONE Study: a Prospective Study on Feasibility, Safety and Accuracy

EPIBONE
Start date: July 1, 2024
Phase: N/A
Study type: Interventional

Interventional clinical study to obtain performance and safety data of the EPIONE® device when used for bone percutaneous procedures.

NCT ID: NCT06235034 Not yet recruiting - Bone Metastases Clinical Trials

Diagnostic CT Palliative Radiotherapy: Feasibility Study of Treating Bone Metastases Without a CT Simulation

dCT-PRT
Start date: January 20, 2024
Phase: N/A
Study type: Interventional

The purpose of this non-randomized, prospective study is to assess the feasibility of planning and delivering conventional palliative radiotherapy to bone metastases on previously available diagnostic CT scans (dCT). Objectives:1) dosimetric accuracy of palliative radiotherapy designed on a dCT compared to a CT simulation 2) assess suitability of patient set up using surface landmarks and kilo voltage (kV) imaging 3) determine the proportion of patients who can receive radiotherapy designed on a dCT 4) confirm eligibility criteria for appropriate patients in clinical practice All enrolled patients will undergo a CT simulation with tattoos as per current standard of care.The radiation oncologist will place fields on the dCT and CT simulation. Radiotherapy will be planned on both CT scans and reviewed for quality by both the radiation oncologist and medical physicist.

NCT ID: NCT06023420 Not yet recruiting - Bone Metastases Clinical Trials

Efficacy of a Herbal Formula for Bone Metastases

Start date: February 1, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

RATIONALE: Nearly 50% of patients with bone metastases develop one or more complications collectively termed skeletal-related events (SREs). The study herbal medicine might reduce the morbidities due to "Skeletal-related events" (SRES), and extend survival time. PURPOSE: the study is to explore the effects of the 4 Herbs Formula on the reduction of "Skeletal-related events" (SRES), and survival time.

NCT ID: NCT05969470 Not yet recruiting - Bone Metastases Clinical Trials

Short Versus Long Intramedullary Nails in the Treatment of Proximal Femur Metastasis.

Start date: August 31, 2023
Phase: N/A
Study type: Interventional

The goal of this interventional randomized controlled trial is to compare the clinical outcomes in treating extremities pathological fractures (fractures of limbs caused by metastatic tumors) or impending pathological fractures with short or long intramedullary nails. The main questions it aims to answer are: 1. What is the rate of developing new distant metastasis of the operated extremities? 2. Does treating extremities (impending) pathological fractures with long intramedullary nails have lower or similar reoperation rate than the short nails? 3. Are there any differences when comparing the surgical-related complication, functional outcomes and life quality assessment between treating extremities (impending) pathological fractures with long or short intramedullary nails. Participants who meet surgical indication will be randomized into either the long or short intramedullary nail group after informed consent. The patient will receive bone fixation with the corresponding prosthesis.

NCT ID: NCT05730972 Not yet recruiting - Clinical trials for Non Small Cell Lung Cancer

TEAS for the Treatment of Pain in Bone Metastases of Lung Cancer

Start date: December 15, 2023
Phase: N/A
Study type: Interventional

This multicenter, prospective, randomized controlled research study aims to objectively evaluate the role of transcutaneous electrical acupoint stimulation (TEAS), which combines the theory of acupuncture with transcutaneous electrical nerve stimulation (TENS) therapy, for the treatment of pain in patients with bone metastases from lung cancer.

NCT ID: NCT05665790 Not yet recruiting - Bone Metastases Clinical Trials

Primary Lesion Treatment for Bone Metastases

Start date: March 2023
Phase: N/A
Study type: Interventional

This study will carry out a prospective cohort study to study the effect of different primary leison treatment modes on disease control, quality of life, economic cost and survival period of patients with bone metastases from breast cancer and lung cancer by giving radiotherapy or palliative surgery or not giving local treatment for the primary lesion in patients with bone metastases from breast cancer or lung cancer

NCT ID: NCT05665439 Not yet recruiting - Bone Metastases Clinical Trials

Local Treatment for Bone Metastases

Start date: March 2023
Phase: N/A
Study type: Interventional

This study will carry out a prospective randomized controlled study to study the effect of different local treatment on disease control, quality of life, economic cost and even survival period of patients by randomly giving local radiotherapy or observation to patients with newly diagnosed bone metastases or patients with bone metastases after vertebroplasty.

NCT ID: NCT05597215 Not yet recruiting - Bone Metastases Clinical Trials

Two Bed SPECT/CT Versus Planar Bone Scintigraphy in Detection of Osseous Metastases in Patients With Genitourinary Malignancies

Start date: December 2022
Phase:
Study type: Observational

The study aims to compare the diagnostic performance of planar bone scan and two bed SPECT/CT in detection of bone metastases in patients with urogenital cancer.

NCT ID: NCT05495802 Not yet recruiting - Bone Metastases Clinical Trials

Regional Database for Collecting Clinical-biological and Imaging Data "Secondary Bone Oncology and Bone Localizations of Hematologic Diseases"

OOSLOH
Start date: December 2022
Phase:
Study type: Observational

Improving the effectiveness of cancer treatments makes it possible to lengthen patient survival. It is therefore important to ensure that the quality of life is also maintained by reducing pain and handicap. Some cancers tend to spread to the bone. The bone locations of cancer can weaken the bone and lead to complications such as fractures, pain, or compression of neurological structures. To avoid such complications, weekly multidisciplinary meetings (MM) bring together specialists (oncologists, rheumatologists, cancer surgeons, radiologists, radiotherapists, etc.) to discuss the files of patients with bone lesions from cancer. They offer specific treatments adapted to each patient to treat or reduce the risk of complications. The OOSLOH study aims to collect clinical, biological, and imaging data from patients for whom a discussion took place in bone dedicated MM. Based on these data, epidemiological studies could be carried out to better understand the clinical factors leading cancer to colonize bone. But also to determine the factors making it possible to prevent or better treat bone complications and improve the quality of life of patients. This study does not require any examinations or additional visits to the patient

NCT ID: NCT05466812 Not yet recruiting - Bone Metastases Clinical Trials

Efficacy of Sr-89 for Differentiated Thyroid Cancer With Bone Metastases

Start date: July 13, 2022
Phase: Phase 4
Study type: Interventional

Using sensitive markers (such as thyroglobulin, etc) to evaluate the efficacy of strontium-89 chloride (Sr-89) in differentiated thyroid cancer with bone metastases with an aim to breaking out of its palliation effect for bone pain.